Browse > Article
http://dx.doi.org/10.15324/kjcls.2022.54.4.265

Epidemiological Study of KPC-2 Producing Klebsiella pneumoniae Isolated in Daejeon During a 4-Year Period  

Hye Hyun, Cho (Department of Biomedical Laboratory Science, Daejeon Institute of Science and Technology)
Publication Information
Korean Journal of Clinical Laboratory Science / v.54, no.4, 2022 , pp. 265-272 More about this Journal
Abstract
The emergence and dissemination of carbapenemase-producing Enterobacteriaceae (CPE), particularly the Klebsiella pneumoniae carbapenemase-2 (KPC-2) producing Klebsiella pneumoniae, has been rapidly increasing worldwide and is becoming a serious public health threat. Since the epidemiology and characteristics of these KPC-2-producing K. pneumoniae vary according to the region and period under consideration, this study investigated the prevalence of carbapenemases and the epidemiological relationship of 78 carbapenem-resistant K. pneumoniae (CRKP) isolated from a tertiary hospital in Daejeon, from March 2017 to December 2020. The antimicrobial susceptibility tests were identified using the disk-diffusion method. PCR and DNA sequencing were used to determine the carbapenemase genes. In addition, molecular epidemiology was performed by multilocus sequence typing (MLST). Among the 78 CRKP isolates, 35 isolates (44.9%) were carbapenemase-producing K. pneumoniae (CPKP) and the major carbapenemase type was KPC-2 (30 isolates, 85.7%). The New Delhi metallo-enzyme-1 (NDM-1) and NDM-5 were identified in 4 isolates (11.4%) and 1 isolate (2.9%), respectively. Multilocus sequence typing (MLST) analysis showed 10 sequence types (STs) and the most prevalent ST was ST307 (51.4%, 18/35). All the ST307 isolates were KPC-2-producing K. pneumoniae and were multidrug-resistant (MDR). In addition, ST307 has gradually emerged during a four-year period. These findings indicate that continuous monitoring and proper infection control are needed to prevent the spread of KPC-2-producing K. pneumoniae ST307.
Keywords
Beta-lactamase KPC-2; Carbapenemase; Klebsiella pneumoniae;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Pitout JD. Infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs. 2010;70:313-333. https://doi.org/10.2165/11533040-000000000-00000   DOI
2 Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17:1791-1798. https://doi.org/10.3201/eid1710.110655   DOI
3 Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011;55:4943-4960. https://doi.org/10.1128/AAC.00296-11   DOI
4 Iovleva A, Doi Y. Carbapenem-resistant Enterobacteriaceae. Clin Lab Med. 2017;37:303-315. https://doi.org/10.1016/j.cll.2017.01.005   DOI
5 Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228-236. https://doi.org/10.1016/S1473-3099(09)70054-4   DOI
6 Lee EJ, Lee SJ, Bahk HJ, Kim SN, Lee HM. Analysis of carbapenemase-producing Enterobacteriaceae (CPE) surveillance results for 2017 in Korea: comparison with the surveillance results of the previous 5 years (2012-2016). Brief report. Cheongju: KCDC; 2018;11:1586-1594.
7 Hong SK, Yong D, Kim K, Hong SS, Hong SG, Khosbayar T, et al. First outbreak of KPC-2-producing Klebsiella pneumoniae sequence type 258 in a hospital in South Korea. J Clin Microbiol. 2013;51:3877-3879. https://doi.org/10.1128/JCM.01730-13   DOI
8 Yoon EJ, Yang JW, Kim JO, Lee H, Lee KJ, Jeong SH. Carbapenemase-producing Enterobacteriaceae in South Korea: a report from the National Laboratory Surveillance System. Future Microbiol. 2018;13:771-783. https://doi.org/10.2217/fmb-2018-0022   DOI
9 Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill. 2014;19:20939. https://doi.org/10.2807/1560-7917.es2014.19.42.20939   DOI
10 Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015;70:2133-2143. https://doi.org/10.1093/jac/dkv086   DOI
11 Ahn S, Sung JY, Kim H, Kim MS, Hwang Y, Jong S, et al. Molecular epidemiology and characterization of carbapenemase-producing Enterobacteriaceae isolated at a university hospital in Korea during 4-year period. Ann Clin Microbiol. 2016;19:39-47. https://doi.org/10.5145/ACM.2016.19.2.39   DOI
12 Hong JS, Park BY, Kim D, Kim K, Lee KH, Cho NH, et al. Epidemiological study of an outbreak of KPC-2-producing Klebsiella pneumoniae in a tertiary hospital in Korea. Ann Clin Microbiol. 2020;23:81-92. https://doi.org/10.5145/ACM.2020.23.2.5   DOI
13 Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement, M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
14 Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70:119-123. https://doi.org/10.1016/j.diagmicrobio.2010.12.002   DOI
15 Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43:4178-4182. https://doi.org/10.1128/JCM.43.8.4178-4182.2005   DOI
16 Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol. 2014;22:686-696. https://doi.org/10.1016/j.tim.2014.09.003   DOI
17 Bonura C, Giuffre M, Aleo A, Fasciana T, Di Bernardo F, Stampone T, et al. An update of the evolving epidemic of blaKPC carrying Klebsiella pneumoniae in Sicily, Italy, 2014: emergence of multiple non-ST258 clones. PLoS One. 2015;10:e0132936. https://doi.org/10.1371/journal.pone.0132936   DOI
18 Yoo JS, Kim HM, Yoo JI, Yang JW, Kim HS, Chung GT, et al. Detection of clonal KPC-2-producing Klebsiella pneumoniae ST258 in Korea during nationwide surveillance in 2011. J Med Microbiol. 2013;62:1338-1342. https://doi.org/10.1099/jmm.0.059428-0   DOI
19 Jeong S, Kim JO, Yoon EJ, Bae IK, Lee W, Lee H, et al. Extensively drug-resistant Escherichia coli sequence type 1642 carrying an IncX3 plasmid containing the blaKPC-2 gene associated with transposon Tn4401a. Ann Lab Med. 2018;38:17-22. https://doi.org/10.3343/alm.2018.38.1.17   DOI
20 Poirel L, Hombrouck-Alet C, Freneaux C, Bernabeu S, Nordmann P. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis. 2010;10:832. https://doi.org/10.1016/S1473-3099(10)70279-6   DOI
21 Castanheira M, Farrell SE, Wanger A, Rolston KV, Jones RN, Mendes RE. Rapid expansion of KPC-2-producing Klebsiella pneumoniae isolates in two Texas hospitals due to clonal spread of ST258 and ST307 lineages. Microb Drug Resist. 2013;19:295-297. https://doi.org/10.1089/mdr.2012.0238   DOI
22 Bocanegra-Ibarias P, Garza-Gonzalez E, Padilla-Orozco M, Mendoza-Olazaran S, Perez-Alba E, Flores-Trevino S, et al. The successful containment of a hospital outbreak caused by NDM-1-producing Klebsiella pneumoniae ST307 using active surveillance. PLoS One. 2019;14:e0209609. https://doi.org/10.1371/journal.pone.0209609   DOI
23 Biedrzycka M, Urbanowicz P, Guzek A, Brisse S, Gniadkowski M, Izdebski R. Dissemination of Klebsiella pneumoniae ST147 NDM-1 in Poland, 2015-19. J Antimicrob Chemother. 2021;76:2538-2545. https://doi.org/10.1093/jac/dkab207   DOI
24 Patil S, Chen H, Guo C, Zhang X, Ren PG, Francisco NM, et al. Emergence of Klebsiella pneumoniae ST307 co-producing CTX-M with SHV and KPC from paediatric Patients at Shenzhen children's hospital, China. Infect Drug Resist. 2021;14:3581-3588. https://doi.org/10.2147/IDR.S324018   DOI
25 Wei L, Feng Y, Wen H, Ya H, Qiao F, Zong Z. NDM-5-producing carbapenem-resistant Klebsiella pneumoniae of sequence type 789 emerged as a threat for neonates: a multicentre, genome-based study. Int J Antimicrob Agents. 2022;59:106508. https://doi.org/10.1016/j.ijantimicag.2021.106508   DOI
26 Gu B, Bi R, Cao X, Qian H, Hu R, Ma P. Clonal dissemination of KPC-2-producing Klebsiella pneumoniae ST11 and ST48 clone among multiple departments in a tertiary teaching hospital in Jiangsu Province, China. Ann Transl Med. 2019;7:716. https://doi.org/10.21037/atm.2019.12.01   DOI
27 Rad ZR, Rad ZR, Goudarzi H, Goudarzi M, Alizade H, Mazraeh FN, et al. Detection of NDM-1 producing Klebsiella pneumoniae ST15 and ST147 in Iran during 2019-2020. Acta Microbiol Immunol Hung. 2021;68:177-182. https://doi.org/10.1556/030.2021.01381   DOI
28 Gondal AJ, Saleem S, Jahan S, Choudhry N, Yasmin N. Novel carbapenem-resistant Klebsiella pneumoniae ST147 coharboring blaNDM-1, blaOXA-48 and Extended-Spectrum β-Lactamases from Pakistan. Infect Drug Resist. 2020;13:2105-2115. https://doi.org/10.2147/IDR.S251532   DOI
29 Andrade LN, Vitali L, Gaspar GG, Bellissimo-Rodrigues F, Martinez R, Darini AL. Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. J Clin Microbiol. 2014;52:2530-2535. https://doi.org/10.1128/JCM.00088-14   DOI
30 Damjanova I, Toth A, Paszti J, Hajbel-Vekony G, Jakab M, Berta J, et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005-the new 'MRSAs'? J Antimicrob Chemother. 2008;62:978-985. https://doi.org/10.1093/jac/dkn287   DOI